Telix Pharmaceuticals Limited Stock Market Value
| TLX Stock | 15.76 0.16 1.03% |
| Symbol | Telix |
Telix Pharmaceuticals Price To Book Ratio
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Telix Pharmaceuticals. If investors know Telix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Telix Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.09 | Revenue Per Share 1.991 | Quarterly Revenue Growth 0.581 | Return On Assets 0.0797 | Return On Equity 0.2049 |
The market value of Telix Pharmaceuticals is measured differently than its book value, which is the value of Telix that is recorded on the company's balance sheet. Investors also form their own opinion of Telix Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Telix Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Telix Pharmaceuticals' market value can be influenced by many factors that don't directly affect Telix Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Telix Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Telix Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Telix Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Telix Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Telix Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Telix Pharmaceuticals.
| 12/26/2022 |
| 12/15/2024 |
If you would invest 0.00 in Telix Pharmaceuticals on December 26, 2022 and sell it all today you would earn a total of 0.00 from holding Telix Pharmaceuticals Limited or generate 0.0% return on investment in Telix Pharmaceuticals over 720 days. Telix Pharmaceuticals is related to or competes with HUTCHMED DRC, Vestis, Xponential Fitness, HE Equipment, Air Lease, and Alvotech. Telix Pharmaceuticals is entity of United States More
Telix Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Telix Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Telix Pharmaceuticals Limited upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.95 | |||
| Information Ratio | 0.0443 | |||
| Maximum Drawdown | 10.19 | |||
| Value At Risk | (2.14) | |||
| Potential Upside | 4.38 |
Telix Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Telix Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Telix Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Telix Pharmaceuticals historical prices to predict the future Telix Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0692 | |||
| Jensen Alpha | 0.1717 | |||
| Total Risk Alpha | (0.10) | |||
| Sortino Ratio | 0.0548 | |||
| Treynor Ratio | 0.7075 |
Telix Pharmaceuticals Backtested Returns
Telix Pharmaceuticals appears to be not too volatile, given 3 months investment horizon. Telix Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0859, which indicates the firm had a 0.0859% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Telix Pharmaceuticals Limited, which you can use to evaluate the volatility of the company. Please review Telix Pharmaceuticals' Coefficient Of Variation of 1164.67, semi deviation of 1.55, and Risk Adjusted Performance of 0.0692 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Telix Pharmaceuticals holds a performance score of 6. The entity has a beta of 0.28, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Telix Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Telix Pharmaceuticals is expected to be smaller as well. Please check Telix Pharmaceuticals' value at risk, as well as the relationship between the kurtosis and market facilitation index , to make a quick decision on whether Telix Pharmaceuticals' existing price patterns will revert.
Auto-correlation | 0.00 |
No correlation between past and present
Telix Pharmaceuticals Limited has no correlation between past and present. Overlapping area represents the amount of predictability between Telix Pharmaceuticals time series from 26th of December 2022 to 21st of December 2023 and 21st of December 2023 to 15th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Telix Pharmaceuticals price movement. The serial correlation of 0.0 indicates that just 0.0% of current Telix Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Telix Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Telix Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Telix Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Telix Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Telix Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Telix Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Telix Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Telix Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Telix Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Telix Pharmaceuticals Lagged Returns
When evaluating Telix Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Telix Pharmaceuticals stock have on its future price. Telix Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Telix Pharmaceuticals autocorrelation shows the relationship between Telix Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Telix Pharmaceuticals Limited.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Telix Stock Analysis
When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.